» Articles » PMID: 32050235

Prospective 3-arm Study on Pain and Epithelial Healing After Corneal Crosslinking

Overview
Specialty Ophthalmology
Date 2020 Feb 13
PMID 32050235
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: To investigate the effect of 3 regimes on pain and wound healing after corneal crosslinking (CXL).

Setting: Tertiary academic referral center, Utrecht, the Netherlands.

Design: Prospective cohort study.

Methods: Consecutive progressive keratoconus patients who underwent 9 mW/cm epithelium-off CXL were included. Patients received a bandage contact lens (n = 20), occlusive patch (n = 20), or antibiotic ointment (n = 20) after treatment. Pain scores and quality of life, measured by the McGill Pain Questionnaire and Visual Analogue Scale (VAS), were analyzed. Epithelial healing after 2 days, correlations between pain and psychological factors that influence pain perception (depression anxiety stress score and pain catastrophizing score), and oral pain medication were evaluated.

Results: Sixty eyes of 52 patients were analyzed. On average, patients experienced considerable pain after CXL (median VAS score 6.2, range 0 to 10). The postoperative regimen did not significantly affect pain scores, although the antibiotic ointment group reported a higher VAS score (median VAS score 7.2 vs 6.7 and 6.0; P = .57). Occlusive patching showed a trend to quicker resolution of epithelial defects (85% completely healed vs 65% with lenses and 70% with antibiotic ointment; P = .43). Correlations with pain-modulating psychological factors were weak (R < 0.3) and not significant. The use of pain medication corresponded poorly to the prescribed use.

Conclusion: This study demonstrated clinical equivalence of 3 regimes in combating postoperative pain after routine CXL. Wound healing appeared quicker in the occlusive patch group and therefore might be the best standard of care after CXL. The clinical tradition of using bandage contact lenses should be reevaluated.

Citing Articles

Early findings in a randomised controlled trial on crosslinking protocols using isoosmolar and hypoosmolar riboflavin for the treatment of progressive keratoconus.

Gustafsson I, Olafsdottir T, Neumann O, Johansson P, Bizios D, Ivarsen A Acta Ophthalmol. 2024; 103(1):23-32.

PMID: 38970233 PMC: 11704820. DOI: 10.1111/aos.16736.


Performance of Bandage Contact Lens in Patients Post-ocular Surgeries: A Systematic Literature Review.

Zheng Y, Zhai C Eye Contact Lens. 2023; 49(11):449-458.

PMID: 37816246 PMC: 10734785. DOI: 10.1097/ICL.0000000000001021.


Impact of Cross-Linking Procedure on Perioperative Quality of Life in Keratoconus Patients.

Marx-Gross S, Kroell A, Wollschlaeger D, Schuster A, Riedl J, Wasielica-Poslednik J J Clin Med. 2023; 12(11).

PMID: 37298028 PMC: 10253739. DOI: 10.3390/jcm12113833.


Pain mechanisms and management in corneal cross-linking: a review.

van der Valk Bouman E, Pump H, Borsook D, Severinsky B, Wisse R, Saeed H BMJ Open Ophthalmol. 2021; 6(1):e000878.

PMID: 34901466 PMC: 8633999. DOI: 10.1136/bmjophth-2021-000878.